Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?

Elda RighiAlessia CarneluttiUmberto BaccaraniAssunta SartorPiergiorgio CojuttiMatteo BassettiFederico Pea

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)

Our study identified decreased fluconazole Cmin as a factor associated with negative outcomes in liver transplant recipients with Candida infection. TDM of fluconazole may be advisable in this patient population.

Keyphrases

candida albicans
biofilm formation
metabolic syndrome
combination therapy
pseudomonas aeruginosa
young adults
skeletal muscle
smoking cessation
insulin resistance
weight loss
replacement therapy